Find new investment opportunities based on Market Sentiment Indicator. Manage watchlist risk with leading indicator of volatility See what influential analysts and investors are saying about stocks in your watchlist
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
BSX
Boston Scientific
$97.32
Login to see Boston Scientific (BSX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Outperform the market
Risk Analysis
Investors losing their confidence
Technical Indicators
Oversold
Chart
$108.09 (-9.96%)
$104.33 (-6.72%)
$106.04 (-8.22%)
$88.07 (+10.50%)
BSX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
BSX overall standing based on key factors, offering insights into analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
Outperform the market
BSX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BSX Street view is bullish and have positive views on the near-term outlook
Average key support and resistance price levels.
Login to displayBSX Earnings
The TTM reflects 12-month period, providing review of BSX financial performance.
The company financial health has moderately improved over the past year
Financial Score
SYK
370.50
+1.12%
BDX
193.61
+1.05%
TFX
130.90
+4.30%
RMD
278.59
+0.70%
PROF
5.68
+6.97%
What is BSX current stock price?
What are BSX stock strengths?
What risks are associated with BSX stock?
When is BSX next earnings report?
What is BSX market cap and volume?
What is BSX's current Stock IQ?
Should I buy BSX stock right now?
Is BSX a Strong Buy right now?
What does a 'Strong Buy' rating mean for BSX?
What does a 'Strong Sell' rating mean for BSX?
What factors influence BSX's Stock IQ?
FIND US ON
Join over 10,000+ subscribers who value exclusive insights. Stay ahead in the stock market! Enter your email for daily alerts
Stay ahead of the market
Market trends
Investment tips
Market analysis service
Future potential
Informed investment decisions
Investment analysis
IInvestment strategies
In-depth stock analysis
Performance analysis
Stock market insights
Financial trends analysis
Most Trending
+34.28%
+6.50%
-6.76%
+1.93%
+1.43%
BSX
Boston Scientific
Current Price
$97.32
Stock Insights
Strengths
Earnings are forecast to grow
Upgraded on attractively valued
Outperform the market
Risk Analysis
Investors losing their confidence
Technical Indicators
Oversold
Linked to BSX
SYK
370.50
+1.12%
BDX
193.61
+1.05%
TFX
130.90
+4.30%
RMD
278.59
+0.70%
PROF
5.68
+6.97%
Login to unlock Boston Scientific (BSX) Stock IQ rating and get instant clarity on whether to Buy, Hold, or Avoid
Chart
$108.09 (-9.96%)
$104.33 (-6.72%)
$106.04 (-8.22%)
$88.07 (+10.50%)
BSX Analysts Opinion
BSX Overall standing by considering key factors, reflecting analysts perspectives and market expectations.
Hover over the category for more information
Earnings
Earnings
Reported a strong earnings
Above analyst estimates
Rating
Rating
Upgraded on attractively valued
Momentum
Momentum
Has been gaining momentum
Activity
Activity
Investors losing their confidence
Future
Future
Earnings are forecast to grow
Outperform the market
BSX Analysts opinion is positive and also has improved from the past 3 months
Analysts perspectives on the stock desirability, trend direction, and growth potential.
BSX Street view is bullish and have positive views on the near-term outlook
BSX has Low Risk Level based on volatility, sector strength, volume, investor confidence, and outlook. Click here to check what is your level of risk
Average key support and resistance price levels.
Login to displayBSX Earnings
The TTM data reflects the most recent 12-month period, providing overview of BSX financial performance.
BSX Financial Health
The company financial health has moderately improved over the past year
Financial Score
BSX Latest Analysis
Peter Lynch Detailed Fundamental Analysis - BSX. Below is Valideas guru fundamental report for BOSTON SCIENTIFIC CORP (BSX). Of the 22 guru strategies we follow BSX rates highest using our P/E/Growth Investor model based on the published strategy of Peter Lynch. This strategy looks for stocks trading at a reasonable price re
Today
Down 10.3% in 4 Weeks Heres Why You Should You Buy the Dip in Boston Scientific (BSX). Boston Scientific (BSX) has become technically an oversold stock now which implies exhaustion of the heavy selling pressure on it. This combined with strong agreement among Wall Street analysts in revising earnings estimates higher indicates a potential trend reversal for the stock in the near term.
Today
Barclays Maintains Boston Scientific (BSX) Overweight Recommendation. Fintel reports that on October 2 2025 Barclays maintained coverage of Boston Scientific (NYSE:BSX) with a Overweight recommendation. Analyst Price Forecast Suggests 31.18% Upside
Today
RBC Capital Maintains a Buy on Boston Scientific Corporation (BSX) With a $125 PT. Boston Scientific Corporation (NYSE:BSX) is one of the best medical stocks to buy now. On September 29 RBC Capital analyst Shagun Singh Chadha maintained a Buy rating on Boston Scientific Corporation (NYSE:BSX) and set a price target of $125.00. Boston Scientific Corporation (NYSE:BSX) reported in its fiscal Q2 2025 earnings that net sales for the [….]
Today
Truist Securities Maintains Boston Scientific (BSX) Buy Recommendation. Fintel reports that on October 1 2025 Truist Securities maintained coverage of Boston Scientific (NYSE:BSX) with a Buy recommendation. Analyst Price Forecast Suggests 31.73% Upside
Thu Oct 2, 2025
Canaccord Genuity Maintains Boston Scientific (BSX) Buy Recommendation. Fintel reports that on October 1 2025 Canaccord Genuity maintained coverage of Boston Scientific (NYSE:BSX) with a Buy recommendation. Analyst Price Forecast Suggests 31.73% Upside
Thu Oct 2, 2025
Leerink Partners Maintains Boston Scientific (BSX) Outperform Recommendation. Fintel reports that on October 1 2025 Leerink Partners maintained coverage of Boston Scientific (NYSE:BSX) with a Outperform recommendation. Analyst Price Forecast Suggests 31.73% Upside
Thu Oct 2, 2025
Baird Maintains Boston Scientific (BSX) Outperform Recommendation. Fintel reports that on October 1 2025 Baird maintained coverage of Boston Scientific (NYSE:BSX) with a Outperform recommendation. Analyst Price Forecast Suggests 31.73% Upside
Thu Oct 2, 2025
Boston Scientific To Rally More Than 35%? Here Are 10 Top Analyst Forecasts For Wednesday. Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes including upgrades and downgrades please see our analyst ratings page.Telsey Advisory Group raised ) price target from $24 to $29. Telsey Advisory Group analyst Dana Telsey maintained a Market Perform rating. Victoria’.s Secret shares closed at $27.14 on Tuesday. See how other analysts
Wed Oct 1, 2025
Elutia Announces Closing of BioEnvelope Business Sale to Boston Scientific Corporation for $88 Million. - Strengthened balance sheet to fully fund development and launch of NXT-41 platform -
Wed Oct 1, 2025
FIND US ON
Unlock the knowledge that 10,000+ subscribers already cherish. Join for exclusive insights and stay ahead in the stock game! Enter your email to receive daily alerts
In-depth stock analysis
Informed investment decisions
Stock market insights
Stock trading tips
Disclaimer:
Past performance, whether from actual results or historical strategy tests, does not guarantee future success. The displayed outcomes are based on strategies not previously available to investors and do not depict the returns achieved by any specific investor.
The Readiness Indicators, Sentiment Indicators, and overall score are derived from a model retrospectively applied using historical data. This model relies on assumptions inherent to it, which may or may not be verifiable and carry potential risks, including losses.
Engaging in active trading may not be suitable for individuals with limited resources, minimal investment or trading experience, or a low-risk tolerance. Proceed with caution as your capital is exposed to risks.
Please note that no offer or solicitation to buy or sell securities, securities derivatives of future products of any kind, or any type of trading or invesment advise, recommendation or strategy, is made, given or endorsed by StocksRunner including any of their affiliates ("TS").
This information is provided for illustrative purposes only. You should not rely on any advice and/or information contained in this website and before making any investment decision. we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice.
Latest Updates
Overview
Trending
Screener
Insights
Top Rated
Momentum
Earnings